Stock Futures Falling as the Trump Rally Falters Ahead of CPI Inflation Data
U.S. stock futures were retreating on Wednesday, extending Tuesday’s declines. It looks like traders are taking stock of the big gains after Donald Trump won the election last week. Dow Jones Industrial Average futures lost 137 points,
Prediction: The Trump Stock Market Rally Is Doomed for This Simple Reason
President-elect Trump has proposed steep tariffs on all imported products. These tariffs could set off a chain of events that ends the stock market rally. Investors have a simple option to deal with the potential disruption.
S&P 500 eclipses 6,000 and Dow surpasses 44,000. Here’s why stocks could keep climbing. The price of bitcoin is falling after ...
1hon MSN
European markets opened higher on Wednesday while Asian stocks followed Wall Street lower as momentum cooled for the torrid ...
US stocks added to records on Tuesday, with the blistering rally since last week slowing slightly as traders prepared to take ...
For a closer look at AIP and how it separates Palantir from the rest of the SaaS universe, read This Stock Is Crushing ...
Rivian Automotive Inc. and Volkswagen Group have launched their upsized joint venture, vowing to join forces to create ...
Morgan Stanley analysts say Tesla will surge if it can expand to be an AI giant, which may be more likely if Elon Musk exerts ...
Learn more about online stock simulators, and how they make learning about stocks as fun and easy as playing a game.
U.S. stock futures traded near the flatline Tuesday night as Wall Street awaited the latest consumer price index data for ...
Tesla shares fell as much as 7% Tuesday, retreating from their earlier gains as a face of the “Trump trade.” Tesla, recently ...
BP p.l.c.'s recent management changes and strategic moves, including the Travel Centers of America acquisition, signal a ...
Shopify's surge added fuel to Canada's strong market rally, helping its benchmark index cross 25,000 for the first time.
AbbVie said a recently acquired drug candidate for schizophrenia missed the key goal in mid-stage studies, pushing its stock ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback